Nuveen’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-549,293
Closed -$32.4M 3595
2022
Q1
$32.4M Buy
549,293
+188,405
+52% +$370K 0.01% 877
2021
Q4
$21.3M Buy
360,888
+51,495
+17% +$190K 0.01% 1196
2021
Q3
$18.3M Buy
309,393
+3,523
+1% +$17K 0.01% 1328
2021
Q2
$18M Sell
305,870
-103,735
-25% -$608K 0.01% 1449
2021
Q1
$24.2M Buy
409,605
+11,323
+3% +$75.9K 0.01% 1181
2020
Q4
$23.5M Buy
398,282
+4,425
+1% +$22.4K 0.01% 1146
2020
Q3
$23.2M Buy
393,857
+41,125
+12% +$246K 0.01% 969
2020
Q2
$20.8M Buy
352,732
+4,824
+1% +$36.5K 0.01% 1021
2020
Q1
$2.21M Buy
347,908
+8,459
+2% +$67.9K ﹤0.01% 2138
2019
Q4
$3.54M Sell
339,449
-75,298
-18% -$548K ﹤0.01% 2165
2019
Q3
$1.63M Buy
414,747
+44,037
+12% +$356K ﹤0.01% 2493
2019
Q2
$5.51M Buy
+370,710
New +$6.7M ﹤0.01% 1932
2018
Q1
Sell
-12,265
Closed -$834K 1161
2017
Q4
$834K Sell
12,265
-65
-0.5% -$4.54K 0.01% 795
2017
Q3
$1.02M Buy
12,330
+5,130
+71% +$407K 0.01% 762
2017
Q2
$674K Buy
+7,200
New +$441K ﹤0.01% 853
2015
Q3
Sell
-18,314
Closed -$1.61K 1635
2015
Q2
$1.61K Buy
18,314
+1,354
+8% +$116K 0.01% 935
2015
Q1
$1.26M Buy
16,960
+4,891
+41% +$345K 0.01% 1070
2014
Q4
$676K Buy
+12,069
New +$634K ﹤0.01% 1303

Other funds holding CLVS